Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ambit's Oncology Drug in Phase III
Ambit's Oncology Drug in Phase III
Ambit's Oncology Drug in Phase III
Submitted by
admin
on April 9, 2014 - 9:34pm
Source:
Yahoo/Zacks.com
News Tags:
Ambit Biosciences
quizartinib
acute myeloid leukemia
Headline:
Ambit's Oncology Drug in Phase III
Do Not Allow Advertisers to Use My Personal information
